Impact Biomedical Inc. (IBO)
NYSE · Healthcare
Impact Biomedical Inc. Operating Income 2022–2025
Impact Biomedical Inc. annual/quarterly operating income history and growth rate from 2022 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Impact Biomedical Inc. operating income for the quarter ending March 31, 2026 was -2.3 M.
- Impact Biomedical Inc. operating income for the twelve months ending March 31, 2026 was -5.1 M.
- Impact Biomedical Inc. annual operating income for 2025 was -4.3 M, a 25.79% increase from 2022.
- Impact Biomedical Inc. annual operating income for 2022 was -3.4 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Impact Biomedical Inc. Operating Income — FAQ
Impact Biomedical Inc. (IBO) operating income over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
What is Impact Biomedical Inc.'s operating income?
Impact Biomedical Inc. (IBO) reported operating income of -$4M for fiscal 2025.
Where can I see IBO's operating income history?
The chart and table above show Impact Biomedical Inc.'s operating income by year and by quarter, including the growth rate.